Matches in SemOpenAlex for { <https://semopenalex.org/work/W2334131740> ?p ?o ?g. }
- W2334131740 endingPage "1665" @default.
- W2334131740 startingPage "1655" @default.
- W2334131740 abstract "Abstract T-type Ca 2+ channels (T channels), particularly Ca v 3.2 among the 3 isoforms, play a role in neuropathic and visceral pain. We thus characterized the effects of RQ-00311651 (RQ), a novel T-channel blocker, in HEK293 cells transfected with human Ca v 3.1 or Ca v 3.2 by electrophysiological and fluorescent Ca 2+ signaling assays, and also evaluated the antiallodynic/antihyperalgesic activity of RQ in somatic, visceral, and neuropathic pain models in rodents. RQ-00311651 strongly suppressed T currents when tested at holding potentials of −65 ∼ −60 mV, but not −80 mV, in the Ca v 3.1- or Ca v 3.2-expressing cells. RQ-00311651 also inhibited high K + -induced Ca 2+ signaling in those cells. In mice, RQ, administered intraperitoneally (i.p.) at 5 to 20 mg/kg or orally at 20 to 40 mg/kg, significantly suppressed the somatic hyperalgesia and visceral pain-like nociceptive behavior/referred hyperalgesia caused by intraplantar and intracolonic administration of NaHS or Na 2 S, H 2 S donors, respectively, which involve the enhanced activity of Ca v 3.2 channels. RQ-00311651, given i.p. at 5 to 20 mg/kg, exhibited antiallodynic or antihyperalgesic activity in rats with spinal nerve injury–induced neuropathy or in rats and mice with paclitaxel-induced neuropathy. Oral and i.p. RQ at 10 to 20 mg/kg also suppressed the visceral nociceptive behavior and/or referred hyperalgesia accompanying cerulein-induced acute pancreatitis and cyclophosphamide-induced cystitis in mice. The analgesic and antihyperalgesic/antiallodynic doses of oral and i.p. RQ did not significantly affect the locomotor activity and motor coordination. Together, RQ is considered a state-dependent blocker of Ca v 3.1/Ca v 3.2 T channels and may serve as an orally available analgesic for treatment of neuropathic and inflammatory pain including distinct visceral pain with minimum central side effects." @default.
- W2334131740 created "2016-06-24" @default.
- W2334131740 creator A5017615882 @default.
- W2334131740 creator A5021598595 @default.
- W2334131740 creator A5026511895 @default.
- W2334131740 creator A5028324995 @default.
- W2334131740 creator A5028744589 @default.
- W2334131740 creator A5031334106 @default.
- W2334131740 creator A5058939295 @default.
- W2334131740 creator A5060783553 @default.
- W2334131740 creator A5066394356 @default.
- W2334131740 creator A5088404135 @default.
- W2334131740 creator A5088676109 @default.
- W2334131740 date "2016-03-23" @default.
- W2334131740 modified "2023-10-13" @default.
- W2334131740 title "Therapeutic potential of RQ-00311651, a novel T-type Ca2+ channel blocker, in distinct rodent models for neuropathic and visceral pain" @default.
- W2334131740 cites W1521727449 @default.
- W2334131740 cites W1581711342 @default.
- W2334131740 cites W1608867129 @default.
- W2334131740 cites W1630488881 @default.
- W2334131740 cites W1670095596 @default.
- W2334131740 cites W1896839259 @default.
- W2334131740 cites W1942930266 @default.
- W2334131740 cites W1965114407 @default.
- W2334131740 cites W1965866432 @default.
- W2334131740 cites W1966063212 @default.
- W2334131740 cites W1971182858 @default.
- W2334131740 cites W1974621133 @default.
- W2334131740 cites W1975571417 @default.
- W2334131740 cites W1976955691 @default.
- W2334131740 cites W1990327207 @default.
- W2334131740 cites W2001728969 @default.
- W2334131740 cites W2007337144 @default.
- W2334131740 cites W2008054740 @default.
- W2334131740 cites W2010097560 @default.
- W2334131740 cites W2015980149 @default.
- W2334131740 cites W2016678924 @default.
- W2334131740 cites W2021347163 @default.
- W2334131740 cites W2028370794 @default.
- W2334131740 cites W2035634747 @default.
- W2334131740 cites W2036251016 @default.
- W2334131740 cites W2036536447 @default.
- W2334131740 cites W2059306741 @default.
- W2334131740 cites W2061896756 @default.
- W2334131740 cites W2078840491 @default.
- W2334131740 cites W2090729136 @default.
- W2334131740 cites W2091053967 @default.
- W2334131740 cites W2097607539 @default.
- W2334131740 cites W2100683747 @default.
- W2334131740 cites W2100915153 @default.
- W2334131740 cites W2104861960 @default.
- W2334131740 cites W2105893174 @default.
- W2334131740 cites W2124097133 @default.
- W2334131740 cites W2127807428 @default.
- W2334131740 cites W2128865950 @default.
- W2334131740 cites W2136130440 @default.
- W2334131740 cites W2138040251 @default.
- W2334131740 cites W2170387852 @default.
- W2334131740 cites W2172201406 @default.
- W2334131740 cites W2191681147 @default.
- W2334131740 cites W2262873879 @default.
- W2334131740 cites W2327878702 @default.
- W2334131740 cites W2436864104 @default.
- W2334131740 cites W2463512426 @default.
- W2334131740 doi "https://doi.org/10.1097/j.pain.0000000000000565" @default.
- W2334131740 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27023424" @default.
- W2334131740 hasPublicationYear "2016" @default.
- W2334131740 type Work @default.
- W2334131740 sameAs 2334131740 @default.
- W2334131740 citedByCount "27" @default.
- W2334131740 countsByYear W23341317402017 @default.
- W2334131740 countsByYear W23341317402018 @default.
- W2334131740 countsByYear W23341317402019 @default.
- W2334131740 countsByYear W23341317402020 @default.
- W2334131740 countsByYear W23341317402021 @default.
- W2334131740 countsByYear W23341317402022 @default.
- W2334131740 countsByYear W23341317402023 @default.
- W2334131740 crossrefType "journal-article" @default.
- W2334131740 hasAuthorship W2334131740A5017615882 @default.
- W2334131740 hasAuthorship W2334131740A5021598595 @default.
- W2334131740 hasAuthorship W2334131740A5026511895 @default.
- W2334131740 hasAuthorship W2334131740A5028324995 @default.
- W2334131740 hasAuthorship W2334131740A5028744589 @default.
- W2334131740 hasAuthorship W2334131740A5031334106 @default.
- W2334131740 hasAuthorship W2334131740A5058939295 @default.
- W2334131740 hasAuthorship W2334131740A5060783553 @default.
- W2334131740 hasAuthorship W2334131740A5066394356 @default.
- W2334131740 hasAuthorship W2334131740A5088404135 @default.
- W2334131740 hasAuthorship W2334131740A5088676109 @default.
- W2334131740 hasConcept C126322002 @default.
- W2334131740 hasConcept C134018914 @default.
- W2334131740 hasConcept C153461711 @default.
- W2334131740 hasConcept C15490471 @default.
- W2334131740 hasConcept C155164980 @default.
- W2334131740 hasConcept C160145004 @default.
- W2334131740 hasConcept C170493617 @default.
- W2334131740 hasConcept C185592680 @default.
- W2334131740 hasConcept C2777107010 @default.